Syndax Pharmaceuticals Aktie
WKN DE: A2AFL6 / ISIN: US87164F1057
03.03.2025 13:07:57
|
Syndax Pharma Q4 Loss Increases, Misses Estimates
(RTTNews) - Syndax Pharma (SNDX) announced Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$94.17 million, or -$1.10 per share. This compares with -$72.47 million, or -$1.00 per share, last year.
Analysts on average had expected the company to earn -$0.23 per share. Analysts' estimates typically exclude special items.
Syndax Pharma earnings at a glance (GAAP) :
-Earnings: -$94.17 Mln. vs. -$72.47 Mln. last year. -EPS: -$1.10 vs. -$1.00 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Syndax Pharmaceuticals Incmehr Nachrichten
03.08.25 |
Ausblick: Syndax Pharmaceuticals zieht Bilanz zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Syndax Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Syndax Pharmaceuticals Inc | 13,20 | -0,75% |
|